The volume of interstitial fluid (ISF) in the human body is three times that of blood. Yet,
collecting diagnostically useful ISF is more challenging than collecting blood because the …

On-skin wearable systems for biofluid sampling and biomarker sensing can revolutionize the
current practices in healthcare monitoring and personalized medicine. However, there is still …

Detection of biomarkers associated with wound conditions provides in‐depth healthcare
information and benefits wound healing treatment. The current aim of wound detection is to …

Continuous glucose meters (CGMs) have tremendously boosted diabetes care by
emancipating millions of diabetic patients' need for repeated self‐testing by pricking their …

Glucose is critical to all organisms. Herein, we developed a wire electrode embedded
microneedle patch (WEMNP) for in situ real-time detection of glucose in the interstitial fluid …

Microneedles have recently emerged as a powerful tool for minimally invasive drug delivery
and body fluid sampling. To date, high‐resolution fabrication of microneedle arrays (MNAs) …

Continuous real-time monitoring of biomarkers in interstitial fluid is essential for tracking
metabolic changes and facilitating the early detection and management of chronic diseases …

Analyzing interstitial fluid (ISF) via microneedle (MN) devices enables patient health
monitoring in a minimally invasive manner and in point-of-care settings. However, most MN …

Managing diabetes is a chronic challenge today, requiring monitoring and timely insulin
injections to maintain stable blood glucose levels. Traditional clinical testing relies on …

To treat and manage chronic diseases, it is necessary to continuously monitor relevant
biomarkers and modify treatment as the disease state changes. Compared to other bodily …